FDG-PET in Lymphoma: The Deauville Era and Beyond.

Authors

Priyamedha Bose Thakur, Sandip Basu

Published in

PET clinics. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

FDG-positron emission tomography (PET) has augmented lymphoma imaging from morphology-based assessment to functional metabolic evaluation. The introduction of the Deauville five-point scale and its incorporation into the Lugano classification marked the beginning of the "Deauville era" providing a standardized staging and response assessment, enabling risk adapted therapy and prognostication in FDG-avid lymphomas and detection of histologic transformation in lymphomas with low FDG uptake. Beyond visual interpretation, volumetric biomarkers such as metabolic tumor volume and total lesion glycolysis have demonstrated important prognostic value. Emerging Artificial Intelligence applications are further expanding the role of FDG-PET in lymphoma management.

PMID:
42844071
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.